{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:15:36Z","timestamp":1782742536526,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-HLGC-110-03"],"award-info":[{"award-number":["AS-HLGC-110-03"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00415-022-11301-w","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T16:04:15Z","timestamp":1660493055000},"page":"6530-6543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson\u2019s disease"],"prefix":"10.1007","volume":"269","author":[{"given":"Cheng-Hsuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-7573","authenticated-orcid":false,"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,14]]},"reference":[{"key":"11301_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450","journal-title":"Nat Rev Neurosci"},{"key":"11301_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED et al (2015) Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson\u2019s disease. Mov Disord 30:919\u2013927","journal-title":"Mov Disord"},{"key":"11301_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","volume":"88","author":"KF Pedersen","year":"2017","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767\u2013774","journal-title":"Neurology"},{"key":"11301_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovi\u0107","year":"2005","unstructured":"Muslimovi\u0107 D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239","journal-title":"Neurology"},{"key":"11301_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/WNL.56.6.730","volume":"56","author":"D Aarsland","year":"2001","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-S\u00f8rensen P (2001) Risk of dementia in Parkinson\u2019s disease: a community-based, prospective study. Neurology 56:730\u2013736","journal-title":"Neurology"},{"key":"11301_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013) The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84:1258\u20131264","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11301_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","volume":"70","author":"TC Buter","year":"2008","unstructured":"Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D (2008) Dementia and survival in Parkinson disease: a 12-year population study. Neurology 70:1017\u20131022","journal-title":"Neurology"},{"key":"11301_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"11301_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349\u2013356","journal-title":"Mov Disord"},{"key":"11301_CR10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"11301_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1533317514522852","volume":"30","author":"S Zygouris","year":"2015","unstructured":"Zygouris S, Tsolaki M (2015) Computerized cognitive testing for older adults: a review. Am J Alzheimers Dis Other Demen 30:13\u201328","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"11301_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","volume":"82","author":"AJ Yarnall","year":"2014","unstructured":"Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82:308\u2013316","journal-title":"Neurology"},{"key":"11301_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/brain\/awh067","volume":"127","author":"T Foltynie","year":"2004","unstructured":"Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson\u2019s patients in the UK. The CamPaIGN study. Brain 127:550\u2013560","journal-title":"Brain"},{"key":"11301_CR14","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958\u20132969","journal-title":"Brain"},{"key":"11301_CR15","first-page":"399","volume":"85","author":"BJ Sahakian","year":"1992","unstructured":"Sahakian BJ, Owen AM (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85:399\u2013402","journal-title":"J R Soc Med"},{"key":"11301_CR16","first-page":"266","volume":"5","author":"TW Robbins","year":"1994","unstructured":"Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia (Basel, Switzerland) 5:266\u2013281","journal-title":"Dementia (Basel, Switzerland)"},{"key":"11301_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1076\/jcen.25.2.242.13639","volume":"25","author":"CR De Luca","year":"2003","unstructured":"De Luca CR, Wood SJ, Anderson V, Buchanan JA, Proffitt TM, Mahony K, Pantelis C (2003) Normative data from the CANTAB I: development of executive function over the lifespan. J Clin Exp Neuropsychol 25:242\u2013254","journal-title":"J Clin Exp Neuropsychol"},{"key":"11301_CR18","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1017\/S0033291720001142","volume":"51","author":"M Campos-Magdaleno","year":"2021","unstructured":"Campos-Magdaleno M, Leiva D, Pereiro AX, Lojo-Seoane C, Mallo SC, Facal D, Juncos-Rabad\u00e1n O (2021) Changes in visual memory in mild cognitive impairment: a longitudinal study with CANTAB. Psychol Med 51:2465\u20132475","journal-title":"Psychol Med"},{"key":"11301_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000342116","volume":"34","author":"J Junkkila","year":"2012","unstructured":"Junkkila J, Oja S, Laine M, Karrasch M (2012) Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 34:83\u201389","journal-title":"Dement Geriatr Cogn Disord"},{"key":"11301_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis 13:154\u2013156","journal-title":"Neurodegener Dis"},{"key":"11301_CR21","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1021\/cn400129p","volume":"4","author":"MJ Chiu","year":"2013","unstructured":"Chiu MJ, Yang SY, Horng HE, Yang CC, Chen TF, Chieh JJ, Chen HH, Chen TC, Ho CS, Chang SF, Liu HC, Hong CY, Yang HC (2013) Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer\u2019s disease. ACS Chem Neurosci 4:1530\u20131536","journal-title":"ACS Chem Neurosci"},{"key":"11301_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","volume":"88","author":"CH Lin","year":"2017","unstructured":"Lin CH, Yang SY, Horng HE, Yang CC, Chieh JJ, Chen HH, Liu BH, Chiu MJ (2017) Plasma alpha-synuclein predicts cognitive decline in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88:818\u2013824","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11301_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/brain\/awu036","volume":"137","author":"A Hanganu","year":"2014","unstructured":"Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, Chouinard S, Bruneau MA, Mellah S, Belleville S, Monchi O (2014) Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally. Brain 137:1120\u20131129","journal-title":"Brain"},{"key":"11301_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/mds.25982","volume":"29","author":"B Segura","year":"2014","unstructured":"Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C (2014) Cortical thinning associated with mild cognitive impairment in Parkinson\u2019s disease. Mov Disord 29:1495\u20131503","journal-title":"Mov Disord"},{"key":"11301_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11301_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"11301_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"11301_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S1041610294001602","volume":"6","author":"EL Teng","year":"1994","unstructured":"Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D et al (1994) The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6:45\u201358","journal-title":"Int Psychogeriatr"},{"key":"11301_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"JA Yesavage","year":"1986","unstructured":"Yesavage JA, Sheikh JI (1986) 9\/Geriatric Depression Scale (GDS). Clin Gerontol 5:165\u2013173","journal-title":"Clin Gerontol"},{"key":"11301_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738\u20131745","journal-title":"Neurology"},{"key":"11301_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1037\/0033-2909.109.2.163","volume":"109","author":"CM MacLeod","year":"1991","unstructured":"MacLeod CM (1991) Half a century of research on the Stroop effect: an integrative review. Psychol Bull 109:163\u2013203","journal-title":"Psychol Bull"},{"key":"11301_CR32","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97:11050\u201311055","journal-title":"Proc Natl Acad Sci USA"},{"key":"11301_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968\u2013980","journal-title":"Neuroimage"},{"key":"11301_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341\u2013355","journal-title":"Neuron"},{"key":"11301_CR35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnagi.2019.00303","volume":"11","author":"DM Cammisuli","year":"2019","unstructured":"Cammisuli DM, Cammisuli SM, Fusi J, Franzoni F, Pruneti C (2019) Parkinson\u2019s disease-mild cognitive impairment (PD-MCI): a useful summary of update knowledge. Front Aging Neurosci 11:303","journal-title":"Front Aging Neurosci"},{"key":"11301_CR36","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/brain\/awm111","volume":"130","author":"CH Williams-Gray","year":"2007","unstructured":"Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort. Brain 130:1787\u20131798","journal-title":"Brain"},{"key":"11301_CR37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/gps.4261","volume":"30","author":"P Hobson","year":"2015","unstructured":"Hobson P, Meara J (2015) Mild cognitive impairment in Parkinson\u2019s disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int J Geriatr Psychiatry 30:1048\u20131055","journal-title":"Int J Geriatr Psychiatry"},{"key":"11301_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000341998","volume":"11","author":"AA Kehagia","year":"2013","unstructured":"Kehagia AA, Barker RA, Robbins TW (2013) Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener Dis 11:79\u201392","journal-title":"Neurodegener Dis"},{"key":"11301_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","volume":"84","author":"M Zarei","year":"2013","unstructured":"Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Mart\u00ed MJ (2013) Cortical thinning is associated with disease stages and dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 84:875","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11301_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054980","volume":"8","author":"J Pagonabarraga","year":"2013","unstructured":"Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, Garc\u00eda-S\u00e1nchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, G\u00f3mez-Ans\u00f3n B (2013) Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson\u2019s disease. PLoS ONE 8:e54980","journal-title":"PLoS ONE"},{"key":"11301_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado-Alvarado","year":"2016","unstructured":"Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jimenez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov Disord 31:861\u2013881","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"11301_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","volume":"8","author":"D Li","year":"2019","unstructured":"Li D, Mielke MM (2019) An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform. Neurol Ther 8(Suppl 2):73\u201382","journal-title":"Neurol Ther"},{"key":"11301_CR43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","volume":"76","author":"MP Pase","year":"2019","unstructured":"Pase MP, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, DeCarli C, Ch\u00eane G, Dufouil C, Seshadri S (2019) Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes. JAMA Neurol 76:598\u2013606","journal-title":"JAMA Neurol"},{"key":"11301_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, del Campo M (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377","journal-title":"Lancet Neurol"},{"key":"11301_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM (2007) Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64:343\u2013349","journal-title":"Arch Neurol"},{"key":"11301_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2017","unstructured":"Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study. Lancet Neurol 16:66\u201375","journal-title":"Lancet Neurol"},{"key":"11301_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awy347","volume":"142","author":"JC Park","year":"2019","unstructured":"Park JC, Han SH, Yi D, Byun MS, Lee JH, Jang S, Ko K, Jeon SY, Lee YS, Kim YK, Lee DY, Mook-Jung I (2019) Plasma tau\/amyloid-beta1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer\u2019s disease. Brain 142:771\u2013786","journal-title":"Brain"},{"key":"11301_CR48","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"key":"11301_CR49","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90:1234\u20131243","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11301_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","volume":"122","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Holton JL, Revesz T, Dickson DW (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 122:187\u2013204","journal-title":"Acta Neuropathol"},{"key":"11301_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Tredici KD, R\u00fcb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"11301_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/7854_2015_5001","volume":"28","author":"JH Barnett","year":"2016","unstructured":"Barnett JH, Blackwell AD, Sahakian BJ, Robbins TW (2016) The paired associates learning (PAL) test: 30 years of CANTAB translational neuroscience from laboratory to bedside in dementia research. Curr Top Behav Neurosci 28:449\u2013474","journal-title":"Curr Top Behav Neurosci"},{"key":"11301_CR53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuropsychologia.2005.05.010","volume":"44","author":"D Bor","year":"2006","unstructured":"Bor D, Duncan J, Lee AC, Parr A, Owen AM (2006) Frontal lobe involvement in spatial span: converging studies of normal and impaired function. Neuropsychologia 44:229\u2013237","journal-title":"Neuropsychologia"},{"key":"11301_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrn2538","volume":"10","author":"FA Mansouri","year":"2009","unstructured":"Mansouri FA, Tanaka K, Buckley MJ (2009) Conflict-induced behavioural adjustment: a clue to the executive functions of the prefrontal cortex. Nat Rev Neurosci 10:141\u2013152","journal-title":"Nat Rev Neurosci"},{"key":"11301_CR55","first-page":"11","volume":"11","author":"TS Fan","year":"2021","unstructured":"Fan TS, Liu SC, Wu RM (2021) Alpha-synuclein and cognitive decline in Parkinson disease. Life (Basel). 11:11","journal-title":"Life (Basel)."},{"key":"11301_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tics.2013.11.005","volume":"18","author":"M Carreiras","year":"2014","unstructured":"Carreiras M, Armstrong BC, Perea M, Frost R (2014) The what, when, where, and how of visual word recognition. Trends Cogn Sci 18:90\u201398","journal-title":"Trends Cogn Sci"},{"key":"11301_CR57","unstructured":"Gazzaniga M, Ivry RB, Mangun GR (2018) Cognitive neuroscience: fifth international student edition: W.W. Norton)"},{"key":"11301_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuron.2012.01.010","volume":"73","author":"JJ DiCarlo","year":"2012","unstructured":"DiCarlo JJ, Zoccolan D, Rust NC (2012) How does the brain solve visual object recognition? Neuron 73:415\u2013434","journal-title":"Neuron"},{"issue":"Pt 5","key":"11301_CR59","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134(Pt 5):1493\u20131505","journal-title":"Brain"},{"key":"11301_CR60","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1080\/13803395.2018.1485880","volume":"40","author":"SL Flannery","year":"2018","unstructured":"Flannery SL, Jowett T, Garvey A, Cutfield NJ, Machado L (2018) Computerized testing in Parkinson\u2019s disease: performance deficits in relation to standard clinical measures. J Clin Exp Neuropsychol 40:1062\u20131073","journal-title":"J Clin Exp Neuropsychol"},{"key":"11301_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.parkreldis.2015.02.010","volume":"21","author":"CH Lin","year":"2015","unstructured":"Lin CH, Wu RM (2015) Biomarkers of cognitive decline in Parkinson\u2019s disease. Parkinson Relat Disord 21:431\u2013443","journal-title":"Parkinson Relat Disord"},{"key":"11301_CR62","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, Spina S, Allen IE, Cobigo Y, Heuer H, VandeVrede L, Proctor NK, Lago AL et al (2021) Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20:739\u2013752","journal-title":"Lancet Neurol"},{"key":"11301_CR63","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"CC Yang","year":"2018","unstructured":"Yang CC, Chiu MJ, Chen TF, Chang HL, Liu BH, Yang SY (2018) Assay of plasma phosphorylated tau protein (Threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimers Dis 61:1323\u20131332","journal-title":"J Alzheimers Dis"},{"key":"11301_CR64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, Snellman A, Sch\u00f6ll M, Troakes C, Hye A, Gauthier S, Vanmechelen E, Zetterberg H et al (2021) Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol 141:709\u2013724","journal-title":"Acta Neuropathol"},{"key":"11301_CR65","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds PG, Diggle P, Mitchell JD, Parker A, Hasegawa M, Masuda-Suzukake M, Mann DM, Allsop D (2013) A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci Rep 3:2540","journal-title":"Sci Rep"},{"key":"11301_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ejn.13056","volume":"43","author":"SM Williams","year":"2016","unstructured":"Williams SM, Schulz P, Sierks MR (2016) Oligomeric \u03b1-synuclein and \u03b2-amyloid variants as potential biomarkers for Parkinson\u2019s and Alzheimer\u2019s diseases. Eur J Neurosci 43:3\u201316","journal-title":"Eur J Neurosci"},{"key":"11301_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","volume":"599","author":"X Wang","year":"2015","unstructured":"Wang X, Yu S, Li F, Feng T (2015) Detection of \u03b1-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 599:115\u2013119","journal-title":"Neurosci Lett"},{"key":"11301_CR68","first-page":"2545","volume":"141","author":"JH Lanskey","year":"2018","unstructured":"Lanskey JH, McColgan P, Schrag AE, Acosta-Cabronero J, Rees G, Morris HR, Weil RS (2018) Can neuroimaging predict dementia in Parkinson\u2019s disease? Brain 141:2545\u20132560","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11301-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11301-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:07:11Z","timestamp":1667131631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11301-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,14]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["11301"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11301-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,14]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"The study protocols were reviewed by the Institutional Research Board Committee at NTUH and carried out in accordance with relevant regulations. All participants agreed and provided written informed consent before entering the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}